The multicellular tumor spheroid model for high-throughput cancer drug discovery
DV LaBarbera, BG Reid, BH Yoo - Expert opinion on drug …, 2012 - Taylor & Francis
Introduction: For the past 30 years 2D-cell-based assay models have dominated preclinical
cancer drug discovery efforts. 2D-cell-based models fail to predict in vivo efficacy …
cancer drug discovery efforts. 2D-cell-based models fail to predict in vivo efficacy …
The multicellular tumor spheroid model for high-throughput cancer drug discovery
DV LaBarbera, BG Reid… - Expert opinion on drug …, 2012 - pubmed.ncbi.nlm.nih.gov
Introduction For the past 30 years 2D-cell-based assay models have dominated preclinical
cancer drug discovery efforts. 2D-cell-based models fail to predict in vivo efficacy …
cancer drug discovery efforts. 2D-cell-based models fail to predict in vivo efficacy …
The multicellular tumor spheroid model for high-throughput cancer drug discovery.
DV LaBarbera, BG Reid, BH Yoo - Expert Opinion on Drug …, 2012 - europepmc.org
For the past 30 years 2D-cell-based assay models have dominated preclinical cancer drug
discovery efforts. 2D-cell-based models fail to predict in vivo efficacy, contributing to a lower …
discovery efforts. 2D-cell-based models fail to predict in vivo efficacy, contributing to a lower …
[引用][C] The multicellular tumor spheroid model for high-throughput cancer drug discovery
DV LaBarbera, BG Reid, BH Yoo - Expert Opinion on Drug Discovery, 2012 - cir.nii.ac.jp
The multicellular tumor spheroid model for high-throughput cancer drug discovery | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …